STOCK TITAN

March 2026 Stock Losers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 20 of 22 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

See the biggest gainers of March 2026

100

Ranked drops

-82.44%

Largest, IMMP

94.9%

Below baseline, day +5

1.2%

Median recovered, day +5

Filter and sort
Rows

100 ranked drops in March 2026

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank Symbol close to close Session Catalyst Announcement
1 IMMP release reads positive -82.44% against the close of 2026-03-05
Session detail
$56.9M market cap (today)
Clinical Trial Results Release reads positive, stock fell 82.44% TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis

08:00 ET premarket

2 WNW Meiwu Technology Company Limited -79.97% against the close of 2026-03-16
Session detail
$68.5M market cap (today)
Offering / Dilution Meiwu Technology Co Ltd Announces $14 Million Registered Direct Offering

09:25 ET premarket

3 CMBM Cambium Networks Corporation under $25M today -77.34% against the close of 2026-03-25
Session detail
$11.3M market cap (today)
Uplisting / Compliance Cambium Networks Announces Nasdaq Delisting

09:25 ET premarket

4 ALDX Aldeyra Therapeutics, Inc. -70.69% against the close of 2026-03-16
Session detail
$93.5M market cap (today)
Clinical Trial Results Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease

08:30 ET premarket

5 UCAR U Power Limited under $25M today Also on the opposite board this month on both boards -65.08% against the close of 2026-03-18
Session detail
$22.4M market cap (today)
Offering / Dilution U Power Limited Announces Pricing of $6.0 Million Public Offering

08:45 ET premarket

6 NOTE FISCALNOTE HLDG INC A under $25M today More than one ranked move this month 2+ ranked moves -58.57% against the close of 2026-03-25
Session detail
Market cap is not shown because the stored figure disagrees with the share count and price it is derived from.
Uplisting / Compliance FiscalNote Holdings Announces NYSE Notice of Delisting and Appeal Process

18:20 ET after hours

7 PEPG PepGen Inc. -58.16% against the close of 2026-03-30
Session detail
$197.4M market cap (today)
Clinical Trial Results PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data

16:05 ET after hours

8 AARD Aardvark Therapeutics, Inc. -56.20% against the close of 2026-02-27
Session detail
$172.9M market cap (today)
Clinical Trial Results Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

16:05 ET after hours

9 RVPH REVIVA PHARMA HLDGS INC under $25M today -55.43% against the close of 2026-03-18
Session detail
$10.2M market cap (today)
Offering / Dilution Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

16:10 ET after hours

10 RBOT VICARIOUS SRGCL INC A under $25M today -53.18% against the close of 2026-03-02
Session detail
Market cap is not shown because the stored figure disagrees with the share count and price it is derived from.
Uplisting / Compliance Vicarious Surgical Receives Delisting Notice From NYSE

07:00 ET premarket

11 MDCX Medicus Pharma Ltd. under $25M today Also on the opposite board this month release reads positive on both boards -50.88% against the close of 2026-03-04
Session detail
$17.0M market cap (today)
Clinical Trial Results Release reads positive, stock fell 50.88% Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort

07:30 ET premarket

12 WVE Wave Life Sciences Ltd. release reads positive -49.59% against the close of 2026-03-25
Session detail
$1.20B market cap (today)
Clinical Trial Results Release reads positive, stock fell 49.59% Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

07:30 ET premarket

13 ARQ Arq, Inc. -48.75% against the close of 2026-03-09
Session detail
$89.3M market cap (today)
Earnings Arq Reports Fourth Quarter and Full Year 2025 Results

18:39 ET after hours

14 IXHL Incannex Healthcare Limited American -48.41% against the close of 2026-03-11
Session detail
$37.7M market cap (today)
Offering / Dilution Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

08:05 ET premarket

15 BUR Burford Capital Limited -47.13% against the close of 2026-03-26
Session detail
$970.6M market cap (today)
Other Announcement Burford Capital Statement Re YPF Matter

12:58 ET intraday

16 LTRN Lantern Pharma Inc. -46.41% against the close of 2026-03-26
Session detail
$36.5M market cap (today)
FDA & Regulatory Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001

07:29 ET premarket

17 YRD Yiren Digital Ltd. -44.84% against the close of 2026-03-18
Session detail
$110.2M market cap (today)
Earnings Yiren Digital Reports Fourth Quarter and Fiscal Year 2025 Financial Results

07:00 ET premarket

18 VSA VisionSys AI Inc American under $25M today -44.51% against the close of 2026-03-26
Session detail
Market cap is not shown because the stored figure disagrees with the share count and price it is derived from.
Offering / Dilution VisionSys AI Inc. Announces Pricing of $3 Million Registered Direct Offering

14:09 ET intraday

19 SBDS SOLO BRANDS INC A under $25M today -43.95% against the close of 2026-03-18
Session detail
$9.3M market cap (today)
Earnings Solo Brands, Inc. Announces Fiscal 2025 Fourth Quarter and Full Year Results

07:00 ET premarket

20 KLC KinderCare Learning Companies, Inc. -42.65% against the close of 2026-03-12
Session detail
$612.3M market cap (today)
Earnings KinderCare Reports Fourth Quarter 2025 Financial Results

16:10 ET after hours

21 SCNX Scienture Holdings, Inc. under $25M today -42.23% against the close of 2026-03-27
Session detail
$15.4M market cap (today)
Earnings SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update

08:07 ET premarket

22 ALUR ALLURION TECHNOLOGIES INC under $25M today release reads positive -40.08% against the close of 2026-02-27
Session detail
$10.0M market cap (today)
Uplisting / Compliance Release reads positive, stock fell 40.08% Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

09:00 ET premarket

23 FBGL FBS Global Limited under $25M today -38.28% against the close of 2026-03-03
Session detail
$5.7M market cap (today)
Other Announcement FBS Global Highlights Approximately $78.5 Million Secured Project Pipeline Across Public and Commercial Infrastructure

08:05 ET premarket

24 OWLT Owlet, Inc. -38.21% against the close of 2026-03-05
Session detail
$159.9M market cap (today)
Earnings Owlet Reports Fourth Quarter and Full Year 2025 Results; Initiates 2026 Guidance

16:05 ET after hours

25 OTLK Outlook Therapeutics, Inc. -38.06% against the close of 2026-03-23
Session detail
$190.7M market cap (today)
Offering / Dilution Outlook Therapeutics Announces Proposed Public Offering

17:30 ET after hours

26 NSRX Nasus Pharma Ltd. release reads positive -38.00% against the close of 2026-03-13
Session detail
$40.5M market cap (today)
Clinical Trial Results Release reads positive, stock fell 38.00% Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

07:30 ET premarket

27 VALN Valneva SE American release reads positive -37.11% against the close of 2026-03-20
Session detail
$541.2M market cap (today)
Clinical Trial Results Release reads positive, stock fell 37.11% Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

06:45 ET premarket

28 GLND Greenland Energy Company -36.85% against the close of 2026-03-26
Session detail
$102.3M market cap (today)
Contract / Partnership Greenland Energy Company (NASDAQ: GLND) Secures a Strategic Agreement for Advanced Rig Capacity to Support the Onshore Oil Exploration Program in Greenland

15:38 ET intraday

29 SES SES AI Corporation -36.84% against the close of 2026-03-04
Session detail
$207.6M market cap (today)
Earnings SES AI Reports Fourth Quarter and Full Year 2025 Results

16:15 ET after hours

30 PULM Pulmatrix, Inc. under $25M today More than one ranked move this month 2+ ranked moves -36.79% against the close of 2026-02-27
Session detail
$6.1M market cap (today)
M&A / Acquisition (terminated) Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities

08:00 ET premarket

31 PRSO Peraso, Inc. under $25M today Also on the opposite board this month on both boards -35.83% against the close of 2026-03-16
Session detail
$11.3M market cap (today)
Earnings Peraso Announces Fourth Quarter and Full Year 2025 Results

16:05 ET after hours

32 MAZE Maze Therapeutics, Inc. release reads positive -35.24% against the close of 2026-03-24
Session detail
$1.59B market cap (today)
Clinical Trial Results Release reads positive, stock fell 35.24% Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease

07:00 ET premarket

33 AVXL Anavex Life Sciences -34.61% against the close of 2026-03-24
Session detail
$309.5M market cap (today)
Other Announcement Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

07:30 ET premarket

34 MVST Microvast Holdings, Inc. -34.20% against the close of 2026-03-16
Session detail
$301.8M market cap (today)
Earnings Microvast Reports 2025 Financial Results

17:00 ET after hours

35 ORGN Origin Materials, Inc. under $25M today -34.15% against the close of 2026-03-27
Session detail
$5.4M market cap (today)
Earnings Origin Materials, Inc. Reports Operating and Financial Results for Fourth Quarter and Full Year 2025

16:41 ET after hours

36 HELP -33.88% against the close of 2026-03-04
Session detail
$719.6M market cap (today)
Clinical Trial Results Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder

07:30 ET premarket

37 AGIG Abundia Global Impact Group Inc. -33.82% against the close of 2026-03-02
Session detail
$36.5M market cap (today)
Other Announcement Abundia Global Impact Group to Participate in Water Tower Research Fireside Chat on Wednesday, March 4, 2026

08:00 ET premarket

38 ICCM IceCure Medical Ltd. under $25M today -33.66% against the close of 2026-03-25
Session detail
$10.6M market cap (today)
Offering / Dilution IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement

08:00 ET premarket

39 SMCI Super Micro Computer, Inc. -33.32% against the close of 2026-03-19
Session detail
$14.73B market cap (at the time of the move, reconstructed)
Other Announcement Super Micro Computer Issues Statement on Action by U.S. Attorney's Office

18:49 ET after hours

40 LFCR Lifecore Biomedical, Inc. -33.26% against the close of 2026-03-13
Session detail
$189.6M market cap (today)
Earnings Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update

08:00 ET premarket

41 LNSR LENSAR, Inc. -32.85% against the close of 2026-03-16
Session detail
$74.2M market cap (today)
M&A / Acquisition (terminated) LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC

16:30 ET after hours

42 QURE uniQure N.V. release reads positive -32.82% against the close of 2026-02-27
Session detail
$3.22B market cap (today)
FDA & Regulatory Release reads positive, stock fell 32.82% uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease

07:00 ET premarket

43 VRDN Viridian Therapeutics, Inc. release reads positive -32.35% against the close of 2026-03-27
Session detail
$2.67B market cap (today)
Clinical Trial Results Release reads positive, stock fell 32.35% Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease

07:01 ET premarket

44 AMPG AMPLITECH GROUP INC. COM release reads positive -32.08% against the close of 2026-03-26
Session detail
$147.0M market cap (today)
Earnings Release reads positive, stock fell 32.08% AmpliTech Group Reports Fiscal Year 2025 Results With 165% Revenue Growth and Strategic Expansion Into 5G Infrastructure

16:15 ET after hours

45 DTCX Datacentrex, Inc. -31.72% against the close of 2026-03-26
Session detail
$79.7M market cap (today)
Offering / Dilution Datacentrex Announces Proposed Public Offering

16:05 ET after hours

46 GSIW Garden Stage Limited under $25M today release reads positive -31.56% against the close of 2026-03-03
Session detail
$23.5M market cap (today)
Other Announcement Release reads positive, stock fell 31.56% Garden Stage Limited Announces 200 for 1 Share Consolidation of Class A Shares

08:00 ET premarket

47 ROMA Roma Green Finance Limited -31.27% against the close of 2026-03-27
Session detail
$530.1M market cap (today)
Buyback / Dividend Roma Green Finance Limited Announces US$100.0 Million Share Repurchase Program

06:30 ET premarket

48 CING Cingulate Inc. release reads positive -31.05% against the close of 2026-03-17
Session detail
$71.9M market cap (today)
Earnings Release reads positive, stock fell 31.05% Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

08:00 ET premarket

49 FUFU BitFuFu Inc. -30.67% against the close of 2026-03-19
Session detail
$216.6M market cap (today)
Earnings BitFuFu Announces Unaudited 2025 Full-Year Financial Results

06:00 ET premarket

50 GSIT GSI Technology -30.17% against the close of 2026-03-17
Session detail
$257.9M market cap (today)
M&A / Acquisition GSI Technology Concludes Strategic Alternatives Review

08:30 ET premarket

51 DERM Journey Medical Corporation -30.01% against the close of 2026-03-25
Session detail
$177.0M market cap (today)
Earnings Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

16:01 ET after hours

52 LMRI Lumexa Imaging Holdings, Inc. -29.84% against the close of 2026-03-25
Session detail
$1.11B market cap (today)
Earnings Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance 

06:00 ET premarket

53 TGEN Tecogen Inc. -29.58% against the close of 2026-03-17
Session detail
$116.4M market cap (today)
Earnings Tecogen Announces Fourth Quarter and Year-End 2025 Results

18:20 ET after hours

54 VERI Veritone, Inc. -29.50% against the close of 2026-03-26
Session detail
$121.8M market cap (today)
Earnings Veritone Reports Preliminary, Unaudited Q4 2025 Results and Announces Strategic Deal with Oracle

16:30 ET after hours

55 KSCP Knightscope, Inc. -29.42% against the close of 2026-03-27
Session detail
$31.6M market cap (today)
Earnings Knightscope Reports 2025 Results, Advances Autonomous Security Force

09:00 ET premarket

56 CJMB Callan JMB Inc. under $25M today release reads positive -29.28% against the close of 2026-03-26
Session detail
$8.9M market cap (today)
Clinical Trial Results Release reads positive, stock fell 29.28% Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement

08:45 ET premarket

57 MVIS Microvision Inc -29.14% against the close of 2026-03-04
Session detail
$79.0M market cap (today)
Earnings MicroVision Announces Fourth Quarter and Full Year 2025 Results

16:05 ET after hours

58 PROF Profound Medical Corp. -29.11% against the close of 2026-03-05
Session detail
$269.3M market cap (today)
Earnings Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results

16:05 ET after hours

59 PSIX Power Solutions International, Inc. -28.97% against the close of 2026-03-02
Session detail
$941.5M market cap (today)
Earnings Power Solutions International Announces Fourth Quarter and Record Full Year 2025 Financial Results

16:14 ET after hours

60 PULM Pulmatrix, Inc. under $25M today More than one ranked move this month 2+ ranked moves -28.77% against the close of 2026-03-25
Session detail
$6.1M market cap (today)
M&A / Acquisition Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

08:00 ET premarket

61 ZKH ZKH Group Limited American -28.66% against the close of 2026-03-18
Session detail
$453.9M market cap (today)
Earnings ZKH Group Limited Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

06:00 ET premarket

62 ACHV Achieve Life Sciences, Inc. release reads positive -28.40% against the close of 2026-03-23
Session detail
$682.7M market cap (today)
Earnings Release reads positive, stock fell 28.40% Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

07:00 ET premarket

63 HROW Harrow, Inc. -27.96% against the close of 2026-03-02
Session detail
$1.51B market cap (today)
Earnings Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance

16:05 ET after hours

64 GO Grocery Outlet Holding Corp. -27.87% against the close of 2026-03-04
Session detail
$980.3M market cap (today)
Earnings Grocery Outlet Holding Corp. Announces Fourth Quarter and Fiscal 2025 Financial Results

16:01 ET after hours

65 NOA North American Construction Group Ltd. -27.76% against the close of 2026-03-11
Session detail
$395.2M market cap (today)
Earnings North American Construction Group Ltd. Announces Results for the Fourth Quarter and Year Ended December 31, 2025

17:52 ET after hours

66 CSTE Caesarstone Ltd. -27.63% against the close of 2026-03-03
Session detail
$79.5M market cap (today)
Earnings Caesarstone Reports Fourth Quarter and Full Year 2025 Financial Results

07:00 ET premarket

67 FTCI FTC Solar, Inc. -27.11% against the close of 2026-03-04
Session detail
$44.9M market cap (today)
Earnings FTC Solar Announces Fourth Quarter 2025 Financial Results

07:45 ET premarket

68 MAIA MAIA Biotechnology, Inc. release reads positive -27.05% against the close of 2026-03-02
Session detail
$86.3M market cap (today)
Offering / Dilution Release reads positive, stock fell 27.05% MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

17:00 ET after hours

69 CSIQ Canadian Solar Inc. -26.94% against the close of 2026-03-18
Session detail
$1.08B market cap (today)
Earnings Canadian Solar Reports Fourth Quarter and Full Year 2025 Results

06:00 ET premarket

70 SGHT Sight Sciences, Inc. -26.80% against the close of 2026-03-04
Session detail
$411.5M market cap (today)
Earnings Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance

16:05 ET after hours

71 DOUG Douglas Elliman Inc. -26.72% against the close of 2026-03-12
Session detail
$161.8M market cap (today)
Earnings Douglas Elliman Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

07:00 ET premarket

72 IRIX Iridex Corp under $25M today -26.67% against the close of 2026-03-26
Session detail
$14.5M market cap (today)
Earnings Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

16:05 ET after hours

73 PHR Phreesia, Inc. -26.56% against the close of 2026-03-30
Session detail
$773.3M market cap (today)
Earnings Phreesia Announces Fourth Quarter Fiscal 2026 Results

16:03 ET after hours

74 TBPH Theravance Biopharma, Inc. -26.33% against the close of 2026-03-02
Session detail
$877.5M market cap (today)
Clinical Trial Results Theravance Biopharma Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost Reduction Actions

08:30 ET premarket

75 DSGR Distribution Solutions Group, Inc. -26.29% against the close of 2026-03-04
Session detail
$1.61B market cap (today)
Earnings Distribution Solutions Group Announces 2025 Full Year and Fourth Quarter Results

07:30 ET premarket

76 HCAT Health Catalyst, Inc -26.26% against the close of 2026-03-12
Session detail
$127.8M market cap (today)
Earnings Health Catalyst Reports Fourth Quarter and Year End 2025 Results

16:05 ET after hours

77 XYF X Financial American -26.19% against the close of 2026-03-25
Session detail
$204.1M market cap (today)
Earnings X Financial Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

16:50 ET after hours

78 AREN The Arena Group Holdings, Inc. -26.17% against the close of 2026-03-16
Session detail
$83.8M market cap (today)
Earnings The Arena Group Reports Q4 and Full Year 2025 Results, Marking First Full Year of Positive Net Income and Major Debt Reduction

16:05 ET after hours

79 CBUS Cibus, Inc. More than one ranked move this month 2+ ranked moves -25.78% against the close of 2026-03-25
Session detail
$138.2M market cap (today)
Offering / Dilution Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants

16:01 ET after hours

80 DXST Decent Holding Inc under $25M today Also on the opposite board this month on both boards -25.57% against the close of 2026-03-04
Session detail
$5.9M market cap (today)
Other Announcement Decent Holding Inc. Launches AI-Powered Senior Care Platform, Targeting the Estimated $4 Trillion Silver Economy in China

09:30 ET intraday

81 GANX Gain Therapeutics, Inc. release reads positive -25.57% against the close of 2026-03-17
Session detail
$77.6M market cap (today)
Clinical Trial Results Release reads positive, stock fell 25.57% Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026

08:15 ET premarket

82 SVRN OceanPal Inc. under $25M today Also on the opposite board this month on both boards -25.48% against the close of 2026-03-13
Session detail
$11.7M market cap (today)
Uplisting / Compliance OceanPal Receives Nasdaq Staff Determination Regarding Minimum Bid Price Deficiency; Intends to Request Hearing Before Independent Panel

17:25 ET after hours

83 NUVB Nuvation Bio Inc. -25.34% against the close of 2026-03-02
Session detail
$2.32B market cap (today)
Earnings Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

16:05 ET after hours

84 RHLD Resolute Holdings Management, Inc. -25.07% against the close of 2026-03-11
Session detail
$1.07B market cap (today)
Earnings Resolute Holdings Reports Fourth Quarter and Full Year 2025 Results

07:05 ET premarket

85 RANI Rani Therapeutics Holdings, Inc. -24.94% against the close of 2026-03-26
Session detail
$89.0M market cap (today)
Earnings Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

16:05 ET after hours

86 CBUS Cibus, Inc. More than one ranked move this month 2+ ranked moves -24.73% against the close of 2026-03-17
Session detail
$138.2M market cap (today)
Earnings Cibus Reports Fourth Quarter Financial Results and Provides Business Update

16:05 ET after hours

87 AKTX Akari Therapeutics plc ADR (0.01 USD) under $25M today -24.72% against the close of 2026-03-17
Session detail
$12.3M market cap (today)
Other Announcement Akari Therapeutics Announces ADS Ratio Change

16:30 ET after hours

88 TME Tencent Music Entertainment Group American -24.65% against the close of 2026-03-16
Session detail
$14.61B market cap (at the time of the move, reconstructed)
Earnings Tencent Music Entertainment Group Announces Fourth Quarter and Full-Year 2025 Unaudited Financial Results

05:00 ET premarket

89 CMTL Comtech Telecommunications -24.54% against the close of 2026-03-16
Session detail
$51.8M market cap (today)
Earnings Comtech Announces Financial Results for Second Quarter of Fiscal 2026

16:12 ET after hours

90 NOTE FISCALNOTE HLDG INC A under $25M today More than one ranked move this month 2+ ranked moves -24.45% against the close of 2026-03-24
Session detail
Market cap is not shown because the stored figure disagrees with the share count and price it is derived from.
Other Announcement FiscalNote Launches PolicyNote MCP in the OpenAI App Store, Significantly Expanding Access to Its Policy Intelligence

07:01 ET premarket

91 SVC Service Properties Trust -24.30% against the close of 2026-03-30
Session detail
$1.07B market cap (today)
Offering / Dilution Service Properties Trust Announces $500 Million Underwritten Public Offering of Common Shares

16:05 ET after hours

92 SLND Southland Holdings, Inc. -24.22% against the close of 2026-03-26
Session detail
$31.4M market cap (today)
Earnings Southland Announces Fourth Quarter & Full Year 2025 Results

17:27 ET after hours

93 FMFC Kandal M Venture Limited under $25M today -24.12% against the close of 2026-03-20
Session detail
$5.2M market cap (today)
Earnings Kandal M Venture Limited Announces Financial Results for the Six Months Ended September 30, 2025

09:31 ET intraday

94 GPRO GoPro, Inc. -24.00% against the close of 2026-03-05
Session detail
$125.6M market cap (today)
Earnings GoPro Announces Fourth Quarter and 2025 Results

16:05 ET after hours

95 JILL J.Jill, Inc. -23.40% against the close of 2026-03-30
Session detail
$282.9M market cap (today)
Earnings J.Jill, Inc. Announces Fourth Quarter and Full Year 2025 Results

06:45 ET premarket

96 SKYX SKYX Platforms Corp. -23.40% against the close of 2026-03-26
Session detail
$164.1M market cap (today)
Earnings SKYX Reports Another Record Quarter with Revenue of $25 Million in Q-4 Demonstrating 8 Consecutive Quarters of Year Over Year Growth with Annual Record Revenue of $92 Million in 2025 Compared to $86 Million in 2024 as it Continues to Grow its Market Penetration

16:05 ET after hours

97 TDUP ThredUp Inc. -23.35% against the close of 2026-03-02
Session detail
$421.6M market cap (today)
Earnings ThredUp Announces Fourth Quarter and Full Year 2025 Results

16:04 ET after hours

98 KLTO Klotho Neurosciences, Inc. -23.35% against the close of 2026-03-03
Session detail
$56.7M market cap (today)
M&A / Acquisition KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR

08:00 ET premarket

99 HRZN Horizon Technology Finance Corporation -23.32% against the close of 2026-03-03
Session detail
$311.0M market cap (today)
Earnings Horizon Technology Finance Announces Fourth Quarter and Full Year 2025 Financial Results

16:15 ET after hours

100 IINN Inspira Technologies Oxy B.H.N. Ltd. under $25M today -23.15% against the close of 2026-03-26
Session detail
$16.2M market cap (today)
Earnings Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates

16:30 ET after hours

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. 341 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, is classed today as a fund, a trust or an index product, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

2 events were left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

1 event was left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.

3 events were left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

4 rows withhold a market cap because the vendor's stored figure disagrees with the share count and price it is derived from by more than a factor of three, counting the filed all-class share count where one exists.

In March 2026, the median decliner had recovered 1.2% of its drop five sessions later; the largest catalyst group was Earnings, 52 of the 100 events, at a median of -27.8%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still below the pre-news close at day +5
Earnings 52 52.0% -27.8% -27.5% 96.2% of 52
Clinical Trial Results 14 14.0% -37.6% -44.9% 100.0% of 14
Offering / Dilution 11 11.0% -38.1% -46.1% 100.0% of 11
Other Announcement 9 9.0% Fewer than 10 events in this group, so no figures are shown.
M&A / Acquisition 5 5.0% Fewer than 10 events in this group, so no figures are shown.

4 other catalyst types, 9 events: Uplisting / Compliance, FDA & Regulatory, Contract / Partnership, Buyback / Dividend.

How much of the drop held

Horizon Still below the pre-news close close to close Median change since the measured close as a share of the drop
Day +1 98.0% of 99 3.0% deeper below baseline, of 99
Day +5 94.9% of 99 1.2% recovered, of 99
Month end 96.8% of 94 5.1% deeper below baseline, of 94
Month end falls before day +5 for 29 of these 94 events, so this row is not a later horizon than the one above it. 94 of the 100 events have a month-end close later than the measured session; 4 have it on the measured session itself, and 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside March 2026

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsLargest drop
NOTEFISCALNOTE HLDG INC A 2Uplisting / Compliance, Other Announcement -58.57%
PULMPulmatrix, Inc. 2M&A / Acquisition -36.79%
CBUSCibus, Inc. 2Offering / Dilution, Earnings -25.78%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsLargest drop
ANEBANEBULO PHARMAC INC 2026-02, 2026-01, 2025-12 -39.05%
MAMOMassimo Group 2026-02, 2025-12 -59.49%
AGIGAbundia Global Impact Group Inc.this month too 2026-02, 2025-12 -26.00%
APUSApimeds Pharmaceuticals US, Inc. 2026-02, 2025-12 -24.14%
AONCAMER ONCOLOGY NETWORK A 2026-01, 2025-12 -45.59%
ENVBEnveric Biosciences, Inc. 2026-01, 2025-12 -47.34%
CLNNClene Inc. 2026-01, 2025-12 -22.03%
SIDUSidus Space, Inc. 2026-01, 2025-12 -27.95%
SMXSMX (Security Matters) Public Limited Company 2026-01, 2025-12 -68.22%
ALTAltimmune, Inc. 2026-01, 2025-12 -22.77%

What the board was made of

Price before the move

  • Under $18 events, 8.0%
  • $1 to $544 events, 44.0%
  • $5 to $2040 events, 40.0%
  • Over $208 events, 8.0%

When the announcement landed

  • Pre-market49.0%
  • Intraday5.0%
  • After hours46.0%

Volume against normal

  • Under 5x17 events, 17.2%
  • 5x to 20x57 events, 57.6%
  • Over 20x25 events, 25.3%

1 event has too little trading history for a relative volume, and is not in the tiers above.

Industry

  • Pharmaceutical Preparations23 events, 23.0%
  • Biological Products, (no Diagnostic Substances)4 events, 4.0%
  • Services-business Services, Nec4 events, 4.0%
  • Surgical & Medical Instruments & Apparatus4 events, 4.0%
  • Semiconductors & Related Devices3 events, 3.0%
  • Agricultural Chemicals2 events, 2.0%

31 other industries, 36 events

Industry not known: 24.0%

When the release and the price disagreed

16 events on this board carry the flag.

Flagged events sat 9.6 percentage points below the rest of the board five sessions later.

Median at day +5, flagged
-40.4%
Median at day +5, not flagged
-30.8%

Against February 2026

100 events in the comparable window.

February 2026 median -29.6%, selected from the 9,966 events in that month's eligible pool

March 2026 median -30.1%, 0.5 points steeper than February 2026. March 2026's median is taken over the 100 ranked rows, selected from the 9,406 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown because the stored figure disagrees with the share count and price it is derived from.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move.

This archive starts at 2020-04, the first month with ranked moves.